You are here:
View which countries have been approved for each type of Gavi support as of 30 November 2015
Since its launch in 2000, Gavi has helped developing countries to prevent more than 7 million future deaths from hepatitis B, Haemophilus influenzae type b, human papillomavirus, Japanese encephalitis, measles, meningitis A, pneumococcal disease, rotavirus diarrhoea and yellow fever.
Concerned about the misuse of Gavi resources? Report it now.
© Gavi 2016
modal window here